ID

32711

Description

Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data:  Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis

Keywords

  1. 13/11/18 13/11/18 -
Copyright Holder

GSK group of companies

Uploaded on

13 de noviembre de 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Estimation of Dose Proportionality of Darapladib - 107038

Repeated Visits: Pharmacokinetics

Pharmacokinetics
Description

Pharmacokinetics

Actual Date
Description

Actual Date

Data type

date

Actual Time
Description

Actual Time

Data type

time

Sample ID
Description

Sample ID

Data type

text

Similar models

Repeated Visits: Pharmacokinetics

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Pharmacokinetics
Actual Date
Item
Actual Date
date
Actual Time
Item
Actual Time
time
Sample ID
Item
Sample ID
text

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial